Growing community of inventors

Perchtoldsdorf, Austria

Maximilian Woisetschlaeger

Average Co-Inventor Count = 5.36

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 17

Maximilian WoisetschlaegerStefanie Urlinger (5 patents)Maximilian WoisetschlaegerChristoph Heusser (5 patents)Maximilian WoisetschlaegerJulia Neugebauer (5 patents)Maximilian WoisetschlaegerEveline Schaadt (5 patents)Maximilian WoisetschlaegerMarta Cosenza (2 patents)Maximilian WoisetschlaegerMaximilian Woisetschlaeger (5 patents)Stefanie UrlingerStefanie Urlinger (16 patents)Christoph HeusserChristoph Heusser (16 patents)Julia NeugebauerJulia Neugebauer (13 patents)Eveline SchaadtEveline Schaadt (8 patents)Marta CosenzaMarta Cosenza (6 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (4 from 3,923 patents)

2. Novartis Pharma Ag (1 from 29 patents)


5 patents:

1. 10899841 - Anti-BAFFR antibody formulations and methods of use thereof

2. 9458240 - Anti-BAFFR antibody formulations

3. 9382326 - Compositions and methods of use for therapeutic antibodies

4. 9340620 - Compositions and methods of use for therapeutic antibodies

5. 8106163 - Compositions and methods of use for therapeutic antibodies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/7/2026
Loading…